Media

Company’s Proprietary Intraoral Lorazepam Spray

November 3, 2014 by bnovak

EASTGATE ACQUISITIONS ANNOUNCES POSTER PRESENTATION OF THE COMPANY’S PROPRIETARY INTRAORAL LORAZEPAM SPRAY AT THE AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS (AAPS) CONFERENCE SALT LAKE CITY and TORONTO, November 3, 2014 (PRNewswire/-) EastGate Acquisitions Corporation ...

Read more

EASTGATE ACQUISITIONS AUGMENTS ITS SUB-MICRON SELF-NANOEMULSIFYING PLATFORM TECHNOLOGY

August 15, 2014 by bnovak

Broad spectrum of delivery forms is directed towards improving patient complianceSALT LAKE CITY and TORONTO, August 15 , 2014 (PRNewswire/-) EastGate ...

Read more

EASTGATE ACQUISITIONS ENTERS INTO A LICENSE AGREEMENT WITH PURINE PHARMA LLC FOR MARKETING AND DISTRIBUTION OF ITS NUTRACEUTICAL AND CONSUMER PRODUCT LINE

July 29, 2014 by bnovak

SALT LAKE CITY and TORONTO, September 29, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of novel formulations and alternative dosage forms of existing biologically active molecules, announces that it has entered into a licensing ...

Read more

A transmucosal Lorazepam spray for treatment of acute seizures: Summary

July 29, 2014 by bnovak

The estimated annual incidence of prolonged epileptic seizures (status epilepticus) in the USA is about 150,000 cases and approximately 400,000 patients that suffer from repetitive seizures. These emergency conditions lead to 40,000 deaths in the USA every year. Control of status epilepticus and repetitive seizures ...

Read more

EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology

July 29, 2014 by bnovak

New pharmaceutical development opens up entry into blockbuster marketsSALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ -- EastGate AcquisitionsCorporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug deliveryinnovations in the development of improved novel formulations and alternative...

Read more

EASTGATE ACQUISITIONS RECEIVES RESEARCH GRANT FROM ONTARIO BRAIN INSTITUTE

June 25, 2014 by bnovak

SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire/-- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules ...

Read more

EASTGATE ACQUISITIONS ENTERS INTO WORKING COLLABORATION WITH LEADING NEUROLOGIST AT TORONTO WESTERN HOSPITAL

June 17, 2014 by bnovak

SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules expands on its pharmaceutical ...

Read more

EASTGATE ACQUISITIONS ANNOUNCES PRESENTATION AT STE’S 3 ANNUAL MICROCAP INVESTOR CONFERENCE

May 28, 2014 by bnovak

SALT LAKE CITY and TORONTO, May 28, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company aimed at utilizing drug delivery innovations for developing of improved novel formulations and alternative dosage forms of existing biologically active molecules, announced today that it will be ...

Read more

EASTGATE ACQUISITIONS PRESENTS AN INTRODUCTION TO ITS SELF-EMULSIFYING PLATFORM DELIVERY SYSTEM FOR ENHANCING BIOAVAILABILITY OF BIOLOGICALLY ACTIVE COMPOUNDS

May 20, 2014 by bnovak

SALT LAKE CITY and TORONTO, May 20, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company aiming to make use of innovations in drug delivery for the development of improved novel formulations and alternative dosage forms for existing biologically active molecules. An introduction and a description ...

Read more

EASTGATE ACQUISITIONS ANNOUNCES COMPLETION OF PRIVATE EQUITY INVESTMENT FINANCING

March 10, 2014 by bnovak

SALT LAKE CITY and TORONTO, Mar. 10, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active ...

Read more
RSS Icon